Locations:
SearchAdvertisement
TRISCEND II trial reports 1-year results
Post hoc analysis of PROTECTED TAVR finds reduced stroke risk in the U.S. but not beyond
SCAI document focuses on technical aspects of care where clear guidance had been lacking
Novel approach outperforms standard of care for post-PVI stenosis and occlusion
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Analysis of STS/ACC TVT Registry finds greatest benefit in patients with prior stroke
The case for a thoughtful approach to CTO and minimally invasive options for CABG
Resourceful approaches to the care of patients with microvascular disease and elevated Lp(a)
Cleveland Clinic case series demonstrates feasibility and safety in diverse patients
Limited data and experience will translate to a cautious rollout
Support for a TAVR-first approach in patients with concurrent valve and coronary disease
Advertisement
Advertisement